Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04316182
Title Cabozantinib in Patients With Hepatocellular Carcinoma (ACTION) (ACTION)
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Fundacion Clinic per a la Recerca Biomedica
Indications

hepatocellular carcinoma

Therapies

Cabozantinib

Age Groups: senior | adult
Covered Countries ESP


No variant requirements are available.